Compare SLP & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLP | CCAP |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Finance: Consumer Services |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.9M | 418.9M |
| IPO Year | 1996 | 2015 |
| Metric | SLP | CCAP |
|---|---|---|
| Price | $18.42 | $9.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $24.00 | $15.86 |
| AVG Volume (30 Days) | 154.1K | ★ 255.1K |
| Earning Date | 04-09-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 12.59% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.43 | 0.42 |
| Revenue | ★ $59,577,000.00 | N/A |
| Revenue This Year | $3.80 | N/A |
| Revenue Next Year | $5.90 | N/A |
| P/E Ratio | $42.84 | ★ $23.62 |
| Revenue Growth | ★ 10.52 | N/A |
| 52 Week Low | $11.09 | $9.88 |
| 52 Week High | $21.01 | $15.76 |
| Indicator | SLP | CCAP |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 30.47 |
| Support Level | $18.22 | N/A |
| Resistance Level | $18.46 | $11.46 |
| Average True Range (ATR) | 0.02 | 0.20 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 50.00 | 12.70 |
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.